Section: Press - posted in 2010

  • Caris Life Sciences Presents Key Findings Related to Plasma Cell Disorders

    Dr. Raul Braylan to present clinical utility data on flow cytometric analysis for patients with plasma cell disorders at the 2010 American Society of Hematology annual meeting Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, ...
    Continue Reading
  • Caris Life Sciences Presents Key New Diagnostic Data at 2010 Annual Meeting of the American College of Gastroenterology (ACG)

    Highlights include: Data from Caris Life Sciences’ DNA mismatch repair (MMR) testing program for Lynch Syndrome Total of 17 Caris poster presentations, three of which received ACG Presidential Poster Awards Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling ...
    Continue Reading
  • Caris Life Sciences Continues to Expand Its Impressive Roster of Leading Pathologists

    Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and blood-based diagnostic technologies, announced today that it has increased its team of field-leading pathologists by more than 20 percent over the past 10 months, adding in excess of 30 new experts since last ...
    Continue Reading
  • Caris Life Sciences Triples Facility Space to Address Increasing Demand

    Caris Life Sciences™, a leading biosciences company focused on driving precise and personalized healthcare, has moved to a new corporate headquarters in order to meet growing demand for its anatomical pathology and molecular profiling services. The new Dallas-area location is three times larger than its previous facility. Located in the high-tech business corridor of Irving, the ...
    Continue Reading
  • Caris Life Sciences Expands Subspecialty Pathology Practice to Urology

    Caris Life Sciences™, a leading biosciences company focused on enabling precise and personalized healthcare, today announced the launch of its urologic pathology practice, available through its subsidiary Caris Diagnostics. The addition of this subspecialty, which is being directed by Rajal B. Shah, M.D., underscores Caris’ commitment to providing high quality, academic-caliber ...
    Continue Reading
  • Prominent Dermatopathologist Evan R. Farmer, M.D., Joins Caris Life Sciences

    Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic technologies, announced today that one of the foremost dermatopathologists in the United States has joined an already unsurpassed team of subspecialists at its subsidiary Caris ...
    Continue Reading
  • Caris Life Sciences Announces Two Senior Vice President Appointments

    Caris Life Sciences™, Inc. — a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic technologies — today announced the appointments of Dan Sawyers as Senior Vice President, Chief Accounting Officer, and Greg Kelly, Senior Vice President of Operations. ...
    Continue Reading
  • Caris Life Sciences Announces Launch of National Cancer Research Observational Registry

    The Caris Registry’s Molecular Data To Help Predict Responses To Cancer Therapy Caris Life Sciences (Caris) – a leading provider of integrated anatomic pathology and oncology testing services, including molecular profiling and Hematology/Oncology – today announced the launch of The Caris Registry℠, a biomarker-driven repository to help predict clinical benefit and patients’ ...
    Continue Reading
  • Caris Diagnostics Announces Name Change of Parent Company to Caris Life Sciences, Inc.

    Caris Diagnostics (Caris Dx) today announced that its parent company’s name will change to Caris Life Sciences, Inc., effective immediately. The new name reflects the Company’s successful evolution into a multi-faceted organization that is pioneering precision healthcare, leading to improved patient outcomes and lowered healthcare costs. Caris Life Sciences is focused on five key areas ...
    Continue Reading